欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DE/H/6250/002
药品名称
Everolimus beta 5 mg Tabletten
活性成分
everolimus 5.0 mg
剂型
Tablet
上市许可持有人
betapharm Arzneimittel GmbH Kobelweg 95 D-86156 Augsburg
参考成员国 - 产品名称
Germany (DE)
2199613
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
Spain (ES)
Malta (MT)
许可日期
2018/06/01
最近更新日期
2024/09/04
药物ATC编码
L01XE10 everolimus
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Labelling
|
M1_3_1_02_EVS_tab_001_03_Core
Date of last change:2024/09/06
PubAR
|
PAR_3987_DC_EverolimusADr Reddys_23 November 2018
Date of last change:2024/09/06
PubAR Summary
|
summaryPAR_3987_DC_EverolimusDr Reddys_23 November 2018_EN
Date of last change:2024/09/06
Final PL
|
final_common_pil_6250_009
Date of last change:2024/09/06
Final Product Information
|
final_common_pl_6250_007
Date of last change:2024/09/06
Final Product Information
|
final_common_spc_6250_007_
Date of last change:2024/09/06
Final SPC
|
final_common_spc_6250_009
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase